Improved sales of CT imaging products and injector systems resulted in record revenues for E-Z-EM in fiscal year 2007 (end-June 2).
The Lake Success, NY-based contrast and virtual colonoscopy developer notched net sales of $137.8 million from continuing operations for the 12-month period, compared with $137.1 million in fiscal year 2006. Earnings from continuing operations were $8.6 million, compared with $8.1 million in the prior fiscal year.
In the fiscal fourth quarter, net sales from continuing operations slipped to $36.7 million, compared with $36.8 million in the previous fiscal year’s fourth quarter. Earnings from continuing operations rose to $2.8 million, compared with $1.6 million in the year-ago quarter.
By AuntMinnie.com staff writers
August 15, 2007
Related Reading
E-Z-EM releases preliminary 2007 financials, August 3, 2007
E-Z-EM to fight Tyco lawsuit, July 2, 2007
E-Z-EM CFO resigns, May 1, 2007
E-Z-EM gets FDA nod for EmpowerMR, April 17, 2007
E-Z-EM grows sales in Q3, April 11, 2007
Copyright © 2007 AuntMinnie.com
















![Axial images from unenhanced calcium score cardiac CT (left) and curved planar reformation images from CT angiography (right) show that higher long-term exposure to air pollution is associated with greater coronary artery calcium and more obstructive coronary artery disease (CAD). Top row: Images in a 68-year-old male patient with higher 10-year mean ambient air pollution exposure (7.9 μg/m3 for particulate matter measuring ≤2.5 μm in diameter [PM2.5] and 17.4 parts per billion [ppb] for NO2) with extensive CAD (coronary artery calcium score [CACS] >1,000 and obstructive CAD [≥70% diameter stenosis]). Bottom row: Images in a 57-year-old female patient with lower 10-year mean ambient air pollution exposure (6.3 μg/m3 for PM2.5 and 4.6 ppb for NO2) with no CAD (CACS = 0 and no obstructive stenosis).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/06/hanneman.r6SMLzkezo.png?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)



